Skip to main content
Clinical Trials/NCT04115540
NCT04115540
Completed
N/A

Transcutaneous Electrical Nerve Stimulation of Penile Nerves for Treatment of Delayed Ejaculation

Stanford University1 site in 1 country20 target enrollmentJanuary 10, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Delayed Ejaculation
Sponsor
Stanford University
Enrollment
20
Locations
1
Primary Endpoint
International Index of Erectile Function (IIEF) Scale Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of this clinical trial is to test the safety and feasibility of using transcutaneous electrical nerve stimulation (TENS) of the penile nerves to reduce intra-vaginal ejaculatory latency time in men with delayed ejaculation (DE). We hypothesize that this type of stimulation, either before or during sexual activity, will reduce latency time. The primary objective of this study is to determine if TENS of the penile nerve helps men with DE subjectively reduce their ejaculatory latency time. The secondary objective is to determine whether their International Index of Erectile Function (IIEF) score improves with treatment.

Registry
clinicaltrials.gov
Start Date
January 10, 2019
End Date
January 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Eisenberg

Associate Professor of Urology

Stanford University

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Sexually active
  • Diagnosed with delayed ejaculation

Exclusion Criteria

  • Less than 18 years old
  • Any condition effecting the participant that would make them unable to operate the interventional device

Outcomes

Primary Outcomes

International Index of Erectile Function (IIEF) Scale Score

Time Frame: Baseline and 12 weeks

Participants were surveyed before testing the device and then at the conclusion of the trial using the International Index of Erectile Function (IIEF) which is a validated multidimensional scale for erectile function and ejaculatory function in men. The questionnaire consists of 3 questions with a scale for each from 0-5 (highest overall score 15, lowest score 0). The higher the score, the better the outcome and vice versa.

Secondary Outcomes

  • Count of Participants With Treatment-related Adverse Events as Assessed by Survey(Up to 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials